美国物理治疗
USPH
85.71
-0.27
-0.31%
美国物理治疗
US · USPH
#3098 按市值排名
上市于 1970
85.71
-0.27
-0.31%
实时 - 追踪5344个代码 - 心跳于129秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.5个百分点。
机构持股
- 机构持股比例
- 109.98% -0.52pp
- 机构数量
- 270 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund98.59%
Hedge Fund4.97%
Public Company3.76%
Individual/Insider2.57%
Government Pension Fund1.05%
Private Company0.91%
Family Office/Trust0.30%
VC/PE Fund0.30%
主要股东 截至 2026-06-30
BlackRock
15.17% · 2.26M 股
Bahl & Gaynor LLC
5.77% · 861.57K 股
Kayne Anderson Rudnick Investment Management, LLC
5.67% · 846.67K 股
Copeland Capital Management, LLC
5.64% · 841.54K 股
Vanguard Capital Management, LLC
5.23% · 780.05K 股
State Street Global Advisors
4.74% · 707.19K 股
Neuberger Berman Investment Advisers LLC
4.01% · 598.89K 股
Eaton Vance Management
3.80% · 566.64K 股
American Century Investment Management
3.74% · 558.82K 股
SouthernSun Asset Management, LLC
3.54% · 527.77K 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 25次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Christopher Reading | Chief Executive Officer | 0.93% |
| Eric Williams | Chief Operating Officer - East | 0.27% |
| Graham Reeve | Chief Operating Officer - West | 0.19% |
| Carey Hendrickson | Chief Financial Officer | 0.19% |
| Kathleen Gilmartin | Independent Director | 0.18% |
| Richard Binstein | General Counsel | 0.16% |
| Reginald Swanson | Independent Director | 0.15% |
| Bernard Harris | Independent Director | 0.14% |
| Michael Mayrsohn | Director | 0.12% |
| Anne Motsenbocker | Independent Director | 0.07% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Myra Davis | Director | Other Acquisition | +1,210 | -- |
| 2026-09-13 | Nchacha Etta | Chief Financial Officer | Other Acquisition | +6,831 | -- |
| 2026-09-10 | Peter Minan | Independent Director | Open Market Acquisition | +6 | $66.50–79.00 |
| 2026-08-19 | Richard Binstein | General Counsel | Sale to Issuer | -450 | $78.00 |
| 2026-08-19 | Eric Williams | Chief Operating Officer - East | Sale to Issuer | -714 | $78.00 |
| 2026-08-19 | Graham Reeve | Chief Operating Officer - West | Sale to Issuer | -762 | $78.00 |
| 2026-08-19 | Jason Curtis | Senior Vice President of Finance & Accounting | Sale to Issuer | -40 | $78.00 |
| 2026-06-08 | Peter Minan | Independent Director | Open Market Acquisition | +780 | $61.50–63.14 |
| 2026-05-19 | Graham Reeve | Chief Operating Officer - West | Sale to Issuer | -762 | $62.24 |
| 2026-05-19 | Jason Curtis | Senior Vice President of Finance & Accounting | Sale to Issuer | -40 | $62.24 |
| 2026-05-18 | Bernard Harris | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Kathleen Gilmartin | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Reginald Swanson | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Peter Minan | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-05-18 | Peter Minan | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-05-18 | Anne Motsenbocker | Independent Director | Other Acquisition | +2,306 | -- |
| 2026-04-26 | Jason Curtis | Senior Vice President of Finance & Accounting | Initial Statement of Beneficial | 0 | -- |
| 2026-03-10 | Graham Reeve | Chief Operating Officer - West | Open Market Disposition | -662 | $78.86 |
| 2026-03-08 | Carey Hendrickson | Chief Financial Officer | Sale to Issuer | -10,000 | -- |
| 2026-03-08 | Graham Reeve | Chief Operating Officer - West | Open Market Disposition | -1,808 | $78.52–82.25 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
美国物理治疗 讨论区 0 条评论